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1015-9584/Copyright ª 2015, Asian SuSummary Objective: Our objective was to compare the perioperative parameters of needle-
assisted and conventional laparoendoscopic single-site adrenalectomy (LESS-A).
Methods: We compared 23 patients undergoing needle-assisted LESS-A with 29 patients under-
going conventional LESS-A at Hiroshima University Hospital between November 2009 and
February 2014. Needle-assisted LESS-A was performed using a MiniLap instrument (Stryker,
San Jose, CA, USA). We used this instrument to protectively retract the liver at the right side
of the tumor and the spleen at the left side by grasping with a Securea endoscopic surgical
spacer (Hogy Medical Co., Ltd., Tokyo, Japan). Various parameters including insufflation time,
estimated blood loss, pain scale, resumption of oral intake, transfusion rate, and complica-
tions were analyzed using the ManneWhitney U test.
Results: In all cases, LESS-A was completed successfully with no major intraoperative compli-
cations. Patients in both treatment groups had similar age, body mass index, sex, and lateral-
ity. Significantly, needle-assisted LESS-A was performed using the transumbilical approach
rather than the subcostal approach. The insufflation time of the needle-assisted LESS-A was
shorter than that of the conventional LESS-A (pZ 0.0335). No patients required intraoperative
or postoperative blood transfusions. Retrospective design and the small sample size are main
limitations of this study.
Conclusion: Needle-assisted LESS-A was performed safely and in a manner that mitigated many
of the difficulties of LESS surgery.
Copyright ª 2015, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.ng authors declare no conflicts of interest.
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Needlescopic-assisted LESS adrenalectomy 71. Introduction
Since the early 1990s, laparoscopic adrenalectomy has
been a standard procedure for the majority of patients with
a surgical adrenal tumor.1 In conventional laparoscopic
adrenalectomy, three or four ports are used. A paradigm
shift in the field of minimally invasive surgery is now un-
derway, and laparoscopy is progressing ever closer toward
scarless surgery. With the advent of multichannel single
ports as well as articulating instruments, laparoendoscopic
single-site (LESS) surgery has been reported and the use of
LESS surgery has increased. Over the past few years there
has been increasing enthusiasm and growing interest in this
novel, minimally invasive surgical technique.2 LESS surgery
has been performed for various urological diseases, and
studies have shown that it results in less pain, shorter
hospital stays, and excellent cosmetic outcomes compared
to other techniques.3 However, the LESS procedure is a
technically challenging approach, which limits broader
application of the technique.4 Surgeons are confronted
with a number of difficulties not evident in conventional
laparoscopy, such as the lack of instrument triangulation,
instrument shaft clashing, and the need for ambidexterity.
LESS adrenalectomy (LESS-A) through umbilical access can
be extremely challenging due to the angle of approach and
the difficulty of organ retraction.
Needlescopic-assisted LESS is a variation of LESS. In this
approach, instead of introducing conventional LESS in-
struments through the multichannel port, additional
needle-like 2e3 mm instruments are used. This results in
minimal trauma to the abdominal wall and is promising for
scarless surgery because the abdominal entry points do not
necessitate closure of the insertion site after instrument
retrieval.5
The main advantage of needlescopic-assisted LESS is
that it overcomes one of the basic limitations of LESS,
which is the lack of instrument triangulation. Additional
instruments are regularly used to retract target tissues, and
retracting the liver in the case of right-sided adrenal sur-
gery and the spleen in the case of left-sided adrenal surgery
are the most common indications of the placement of the
additional instruments.6 In short, needlescopic-assisted
LESS surgery avoids many of the major difficulties encoun-
tered using the single-site approach. In this study, we
compare perioperative parameters between needle-
assisted and conventional LESS-A.
2. Patients and methods
2.1. Participants
We compared 23 patients undergoing needle-assisted LESS-
A with 29 patients undergoing conventional LESS-A at Hir-
oshima University Hospital, Hiroshima, Japan between
November 2009 and February 2014. All patients consented
to LESS-A and additional incisions if necessary. Fifty-two
consecutive patients underwent transperitoneal LESS-A by
two surgeons (S.I and A.M.). S.I. had experienced only three
cases of multiport laparoscopic adrenalectomy and per-
formed most cases of LESS-A (45 cases; 87%). For the first 20
cases, we used only the subcostal approach, but the bytransumbilical approach for female patients after that.
Various parameters including insufflation time, estimated
blood loss, pain scale, resumption of oral intake, trans-
fusion rate, and complications, were analyzed. Convales-
cence was measured by using a visual analog scale (VAS)
ranging from 0 (negligible pain) to 10 (severe discomfort).
2.2. Surgery
Under general anesthesia, the patients were placed in the
60 modified flank position and the operators stood facing
the abdomen between the arcus costalis on the ipsilateral
side and the umbilicus. A 2-cm skin incision and an access
into the peritoneal cavity were made by open laparotomy.
A single-port device was constructed using Lap Protector
(Hakko Co. Ltd., Tokyo, Japan) and a powder-free surgical
glove. The wound retractor was inserted into the incision
site and the upper part of the wound retractor ring was
covered with a size-71/2 surgical glove. The three trocars
were 5-mm EZ trocars (Hakko Co. Ltd.).
To minimize instrument collision, a flexible 5-mm
0 high-definition laparoscope (Olympus, Tokyo, Japan)
was used. Pneumoperitoneum was induced by CO2 gas
insufflation to 12 mmHg. The surgical strategy followed
that for a conventional transperitoneal adrenalectomy.6
Specifically, the Toldt line and the typical vascular land-
marks (inferior vena cava and renal vein for right- and left-
sided adrenal tumors, respectively) were dissected and
exposed using a bent laparoscopic instrument (Roticulator
Endo Dissect; Covidien, Mansfield, MA, USA) and straight
standard instruments. For the right-sided adrenal tumor,
the right liver lobe was retracted using a snake retractor in
the conventional laparoscopic adrenalectomy approach.
We used a 2.3-mm MiniLap instrument (Stryker, San Jose,
CA, USA) in this series. This instrument protectively
retracted the liver on the right side (Fig. 1) and the spleen
on the left side of the tumor (Fig. 2) by grasping the
endoscopic surgical spacer Securea (Hogy Medical Co., Ltd.,
Tokyo, Japan) to avoid a traumatic procedure as cushioning
to retract.
The adrenal veins were identified, controlled with two 5-
mm polymer locking clips (Hem-o-lok, Teleflex Medical,
Research Triangle Park, NC, USA), one proximally and one
distally, and then divided. A 5-mm LigaSure (Covidien) was
used to complete the adrenal gland dissection. After he-
mostasis was ensured, the entire adrenal gland associated
with the tumor was freed within the abdomen. In all cases,
the specimen was retrieved through the Lap Protector
without any further skin incision. A surgical suction drain
was left in place through the surgical port. Transperitoneal
LESS-A was successfully performed for all patients.
3. Results
3.1. Demographics
The patient demographics are listed in Table 1. There was
no conversion to open surgery for any patient. Two pa-
tients, however, were switched to a conventional laparo-
scopic adrenalectomy by the placement of two additional
12-mm trocars. For the remaining 52 patients, the LESS-A
Figure 1 Needle-assisted laparoendoscopic single-site adrenalectomy (right side). (A, B) MiniLap instrument protectively re-
tracts the liver by grasping the endoscopic surgical spacer Securea. (C) The adrenal veins are clipped with Hem-o-lok. (D) The
entire adrenal gland is freed within the abdomen.
Figure 2 Needle-assisted laparoendoscopic single-site adrenalectomy (left side). (A, B) MiniLap instrument protectively retracts
the spleen by grasping the endoscopic surgical spacer Securea. (C) MiniLap instrument protectively retracts the perirenal fat. (D)
The large adrenal gland is freed within the abdomen.
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Table 1 Patient demographics.
Surgical procedure Needle-assisted Conventional p
No. of patients 23 29
Sex
Male 8 (34.8) 15 (51.7) 0.2218
Female 15 (65.2) 14 (48.3)
Laterality
Right 10 (43.5) 16 (55.2) 0.4022
Left 13 (56.5) 13 (44.8)
Age (y) 51.0 (27e75) 55.5 (35e73) 0.2118
Body mass index (kg/m2) 22.7 (18.2e33.0) 23.7 (18.2e34.4) 0.3481
Tumor size (mm) 21.9 (9e45) 22.0 (9e72) 0.9850
Preoperative diagnosis
Primary aldosteronism 14 (60.9) 17 (58.6)
Pheochromocytoma 3 (13.0) 2 (6.9)
Preclinical Cushing’s syndrome 2 (8.7) 5 (17.2)
Cushing’s syndrome 2 (8.7) 3 (10.3)
Nonfunctional adenoma 2 (8.7) 2 (6.9)
Data are presented as n (%) or mean (range).
Needlescopic-assisted LESS adrenalectomy 9was completed successfully without any intraoperative
complications. There was no significant intergroup differ-
ence in age, male-to-female ratio, affected side, body mass
index (BMI), or tumor size. With growing experience, in-
dications can be expanded to include more challenging
cases. The transumbilical approach ratio was used in 65.2%
and 10.3% for the needle-assisted and the conventional
LESS-A, respectively (p < 0.001). The ratio of pheochro-
mocytoma was 13.0% and 6.9% for the needle-assisted and
conventional LESS-A, respectively (p Z 0.4552).3.2. Surgical outcomes
The surgical outcomes are shown in Table 2. In terms of
insufflation time, the needle-assisted LESS-A was signifi-
cantly shorter than the conventional LESS-A (121.4 minutes
vs. 155.9 minutes; p Z 0.0335). There was no significantTable 2 Surgical outcomes.
Surgical procedure Needle-as
Approach
Transumbilical 15 (65.2)
Subcostal 8 (34.8)
Insufflation time (min) 121.4 (79e
Estimated blood loss (mL) 31.1 (6e7
Transfusion 0
Resumption of oral intake (POD), mean 1
Visual analog scale
at POD 1 3.26 (0e1
at discharge 1.56 (0e6
Complication 0 (0)
Postoperative hospital stay (d) 6.3 (4e11
Data are presented as n (%) or mean (range), unless otherwise indica
N.S. Z not significant; POD Z postoperative day.difference in the estimated blood loss of the two groups
(31.1 mL vs. 32.8 mL; p Z 0.8467). None of the patients in
either group required blood transfusion.
The mean visual analog scale was 3.26 and 2.59 on
postoperative Day (POD) 1 and 1.56 and 0.90 at discharge in
the needle-assisted and the conventional LESS-A, respec-
tively. There was no significant difference in pain relief
between the two groups despite the use of needlescopic
instruments. Postoperative hospital stay was significantly
shorter for patients in the needle-assisted LESS-A group
than for those in the conventional LESS-A (6.3 days vs. 8.2
days; p Z 0.0062).
A minor serosal injury occurred in Patient 1 during open
laparotomy and was in situ repaired with intermittent su-
tures before access port insertion (Clavien Grade 1). The
incision was hidden within the umbilicus, and the scar after
insertion of the needlescopic instrument had disappeared
at postoperative 6 months (Fig. 3).sisted Conventional p
3 (10.3) < 0.001
26 (89.7)
234) 155.9 (61e340) 0.0335
5) 32.8 (9e72) 0.8467
0 N.S.
1 N.S.
0) 2.59 (0e5) 0.9592
) 0.90 (0e2)
1 (3.4) 0.3900
) 8.2 (3e14) 0.0062
ted.
Figure 3 Postoperative appearance of patient’s abdomen
after needle-assisted laparoendoscopic single-site
adrenalectomy.
10 S. Inoue et al.4. Discussion
Laparoscopic adrenalectomy has become the gold standard
for the treatment of adrenal tumors and it comes with a
variety of approaches.7 Many investigators have developed
techniques for reducing the number of ports required to
perform safe laparoscopic surgery.8 Although much effort
has been extended to reduce invasiveness in laparoscopic
adrenalectomy further, an incision is ultimately required
for specimen retrieval.9
To date, the main advantage of LESS surgery over con-
ventional laparoscopic surgery has been the improved
cosmetic outcome. We have previously reported that young
patients and female patients who had received LESS-A
were more satisfied with the scar outcomes than were
those who had received conventional laparoscopic adre-
nalectomy.10 The use of only one incision within the um-
bilicus renders selected transperitoneal procedures
scarless. Therefore, the level of patient scar satisfaction
was excellent.11 Zhang et al12 used retroperitoneoscopic
LESS-A for diverse adrenal tumors, and they found that
LESS-A was comparable with conventional LA perioper-
atively. However, the most severe problem of retro-
peritoneoscopic LESS-A is not to realize scarless surgery.
Despite this cosmetic advantage, use of LESS is still not
widespread due to its technical difficulty. LESS surgery
remains a challenging procedure, especially for the tran-
sumbilical approach, because incomplete triangulation and
more complex motion of the articulating instruments limits
effective dissection.13 Moreover, as the target area for
dissection becomes more cranial, dissection with the
transumbilical LESS procedure will become extremely
difficult. We had difficulty driving the instruments and
avoiding internal and external collisions.4 These limitations
are typical of all LESS procedures, reflecting the small
space between the hands of the surgeon and those of the
assistant. The introduction of advanced equipment and
technical modifications has obscured the concept of an
essential triangulation in favor of LESS surgery.14 Toachieve optimal dissection and triangulation, we have to
use articulating instruments.
Needlescopic instruments partially overcome the main
limitation of LESS surgery, namely the lack of instrument
triangulation.4 Needlescopic instruments can be easily
inserted directly in the abdominal wall through a very small
skin incision without the need for abdominal trocar place-
ment and closure of the incision. Using these instruments
prevents conversion of the procedure to conventional
laparoscopic surgery and frees up one access port in the
main abdominal multichannel port that can be used to
house other necessary instruments. Additionally,
needlescopic-assisted LESS-A potentially diminishes the
steep learning curve of conventional LESS-A, even in diffi-
cult cases such as the transumbilical approach or pheo-
chromocytoma, since it resembles conventional
laparoscopic surgery.4 We used 2-mm needlescopic in-
struments in our series, which do not require an incision for
insertion and do not leave a puncture site scar after the
operation. Needlescopic-assisted LESS-A does not compro-
mise the cosmetic outcome in the slightest, which is still
considered the main advantage of LESS-A over conventional
laparoscopic adrenalectomy.
There were some limitations to this study. The small
sample size (52 patients) makes it impossible to state any
general conclusion. No studies have compared needle-
assisted LESS surgery with conventional LESS surgery. A
more extensive randomized comparison between needle-
assisted LESS surgery and conventional LESS surgery using
tools designed to detect differences in morbidity and to
assess cosmetic benefits will ultimately determine the
future of LESS surgery.15 Moreover, at this time, needle-
scopic instruments do not provide enough holding strength,
do not have a rotation function, and require more effort
and concentration to manipulate because of the small jaw.
However, even with these limitations, the instruments
provided powerful support during our series and should be
particularly helpful for beginners at LESS surgery.
We believe that continuing advances in LESS technology
will improve this procedure in the near future.16 LESS sur-
gery still needs to be explored with greater consideration of
related ethical and methodological issues. Ultimately,
needle-assisted LESS-A was performed safely, and avoided
many of the difficulties of LESS surgery.
5. Conclusion
Needle-assisted LESS-A is a technically feasible and safe
procedure that overcomes many of the technical diffi-
culties of conventional LESS surgery, especially in complex
cases. Our main finding in this study is that the insufflation
time of needle-assisted LESS-A was significantly shorter
than that of conventional LESS-A. In the near future, pro-
spective and randomized long-term follow-up data are
needed to establish whether needle-assisted LESS-A should
be the standard option for adrenalectomy.
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